Series A startup

Who invested in IconOVir Bio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$77Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $77MJan 2021
Investors
3
See who backed them

The rounds

  1. Jan 2021
    Series A$77M

    Source recordedSEC filing: $77M sold, first sale Dec 2020

Founders and team

From the SEC filings it signed: 9 on the team.

  • David A. ChangDirector, Promoteri
  • David M. TanenExecutive Officer, Promoteri
  • Heba M. NowyhedExecutive Officeri
  • John A. HuynhExecutive Officeri
  • Joshua A. KazamDirector, Promoteri
  • Julie A. MaltzmanExecutive Officeri
  • Mark A. McCamishExecutive Officer, Directori
  • Nicole M. van de LeuvExecutive Officeri
  • Sean A. AlgeoExecutive Officer, Promoteri

On the board, as filediHelen S. KimJakob S. LovenWilliam S. Kaelin

Everyone who backed them

Google VenturesCorporate VC1round
Polaris PartnersVC firm1round
Wellington PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists IconOVir Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Nextech InvestPrivate equityPer its own site

Quick answers about IconOVir Bio

Who invested in IconOVir Bio?

IconOVir Bio's investors include Google Ventures, Polaris Partners and Wellington Partners.

How much has IconOVir Bio raised?

IconOVir Bio has raised $77M across 1 round since 2021.

When did IconOVir Bio last raise?

IconOVir Bio's most recent round was a Series A of $77M in Jan 2021.

What was IconOVir Bio's biggest round?

Its most recent round, $77M in Jan 2021, is also its largest on record.

Who backed IconOVir Bio first?

IconOVir Bio's first round on record, in Jan 2021, was backed by Google Ventures, Polaris Partners and Wellington Partners.

What stage is IconOVir Bio at?

IconOVir Bio's latest named round is a Series A, in Jan 2021.

Companies like IconOVir Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.